首页 > 最新文献

Health and Quality of Life Outcomes最新文献

英文 中文
Development and validation of the general module of the quality of life instruments for chronic diseases QLICD-GM(V2.0) : a large sample study based on classical test theory and item response theory. 慢性病生命质量量表通用模块QLICD-GM(V2.0)的开发与验证:基于经典测试理论和项目反应理论的大样本研究
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-07 DOI: 10.1186/s12955-026-02493-0
Chonghua Wan, Xiaoqing Zhang, Liyuan Qiao, Wu Li, Ying Chen, Wanrui Ma, Honghong Xue, Peng Quan, Dandan Wang

Objective: The quality of life(QoL) of patients with chronic diseases is a greater concern for both patients and clinicians. This study was aimed to develop and evaluate the second version of the General Module of Quality of Life Instruments for Chronic Diseases (QLICD-GM(V2.0)) by Classical Test Theory (CTT) and Item Response Theory (IRT) .

Methods: Building upon QLICD-GM(V1.0), the scale was developed and validated through a structured process combining qualitative and quantitative methods. The psychometric properties of QLICD-GM(V2.0) were assessed in a sample of 1953 patients with ten chronic diseases, evaluating reliability, validity, responsiveness, and item characteristics under CTT and IRT frameworks.

Results: The final QLICD-GM(V2.0) comprises 28 items across 3 domains and 9 facets. Item-domain correlations were highest for each item within its intended domain, except one. Confirmatory factor analysis indicated good model fit. Criterion validity against SF-36 showed correlations of 0.56 (physical), 0.54 (psychological), and 0.46 (social). Internal consistency was high (Cronbach's α: 0.79-0.98). Significant pre- to post-treatment score differences were found (all p < 0.001), with standardized response means of 0.24 (physical), 0.17 (psychological), and 0.07 (social). IRT analysis indicated all items had discrimination parameters between 1.11 and 1.41, with monotonically increasing location parameters. Average item information amount was approximately 0.33 (physical), 0.54 (psychological), and 0.44(social).

Conclusions: QLICD-GM(V2.0) provides a psychometrically sound, clinically interpretable and responsive measure of generic QoL in chronic patients. It can be used alone or combined with disease-specific modules to monitor benefit and guide treatment and rehabilitation planning.

目的:慢性疾病患者的生活质量(QoL)是患者和临床医生都非常关注的问题。本研究旨在运用经典测验理论(CTT)和项目反应理论(IRT)开发和评价第二版《慢性病生活质量工具通用模块》(QLICD-GM(V2.0))。方法:以QLICD-GM(V1.0)为基础,采用定性与定量相结合的结构化流程进行编制和验证。以1953例10种慢性疾病患者为样本,对QLICD-GM(V2.0)的心理测量特性进行了评估,评估了CTT和IRT框架下的信度、效度、反应性和项目特征。结果:最终的QLICD-GM(V2.0)包括3个领域9个方面的28个项目。项目与领域的相关性在其预期领域内的每个项目中都是最高的,除了一个项目。验证性因子分析表明模型拟合良好。标准效度与SF-36的相关性为0.56(生理)、0.54(心理)和0.46(社会)。内部一致性高(Cronbach’s α: 0.79-0.98)。结论:QLICD-GM(V2.0)提供了一种心理测量学上合理的、临床可解释的、反应性强的慢性患者一般生活质量测量方法。它可以单独使用或与特定疾病模块结合使用,以监测效益并指导治疗和康复计划。
{"title":"Development and validation of the general module of the quality of life instruments for chronic diseases QLICD-GM(V2.0) : a large sample study based on classical test theory and item response theory.","authors":"Chonghua Wan, Xiaoqing Zhang, Liyuan Qiao, Wu Li, Ying Chen, Wanrui Ma, Honghong Xue, Peng Quan, Dandan Wang","doi":"10.1186/s12955-026-02493-0","DOIUrl":"https://doi.org/10.1186/s12955-026-02493-0","url":null,"abstract":"<p><strong>Objective: </strong>The quality of life(QoL) of patients with chronic diseases is a greater concern for both patients and clinicians. This study was aimed to develop and evaluate the second version of the General Module of Quality of Life Instruments for Chronic Diseases (QLICD-GM(V2.0)) by Classical Test Theory (CTT) and Item Response Theory (IRT) .</p><p><strong>Methods: </strong>Building upon QLICD-GM(V1.0), the scale was developed and validated through a structured process combining qualitative and quantitative methods. The psychometric properties of QLICD-GM(V2.0) were assessed in a sample of 1953 patients with ten chronic diseases, evaluating reliability, validity, responsiveness, and item characteristics under CTT and IRT frameworks.</p><p><strong>Results: </strong>The final QLICD-GM(V2.0) comprises 28 items across 3 domains and 9 facets. Item-domain correlations were highest for each item within its intended domain, except one. Confirmatory factor analysis indicated good model fit. Criterion validity against SF-36 showed correlations of 0.56 (physical), 0.54 (psychological), and 0.46 (social). Internal consistency was high (Cronbach's α: 0.79-0.98). Significant pre- to post-treatment score differences were found (all p < 0.001), with standardized response means of 0.24 (physical), 0.17 (psychological), and 0.07 (social). IRT analysis indicated all items had discrimination parameters between 1.11 and 1.41, with monotonically increasing location parameters. Average item information amount was approximately 0.33 (physical), 0.54 (psychological), and 0.44(social).</p><p><strong>Conclusions: </strong>QLICD-GM(V2.0) provides a psychometrically sound, clinically interpretable and responsive measure of generic QoL in chronic patients. It can be used alone or combined with disease-specific modules to monitor benefit and guide treatment and rehabilitation planning.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146137206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life scores using SF-12 and SF-36v2 questionnaires for patients with multidrug-resistant tuberculosis in Vietnam. 使用SF-12和SF-36v2问卷对越南耐多药结核病患者的生活质量评分
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1186/s12955-026-02479-y
Nguyen Thi Lien Ha, Nguyen Binh Hoa, Manisha Yapa, Nguyen Thu Anh, Qingbin Li, Vu Hai Dang, Greg J Fox, Vu Quoc Dat
{"title":"Quality of life scores using SF-12 and SF-36v2 questionnaires for patients with multidrug-resistant tuberculosis in Vietnam.","authors":"Nguyen Thi Lien Ha, Nguyen Binh Hoa, Manisha Yapa, Nguyen Thu Anh, Qingbin Li, Vu Hai Dang, Greg J Fox, Vu Quoc Dat","doi":"10.1186/s12955-026-02479-y","DOIUrl":"https://doi.org/10.1186/s12955-026-02479-y","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146124793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing electronic Patient-Reported Outcome Measures in Chronic Kidney Disease: a qualitative systematic review of barriers, enablers, and mechanisms. 在慢性肾脏疾病中实施电子患者报告的结果测量:对障碍、促成因素和机制的定性系统回顾。
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-06 DOI: 10.1186/s12955-026-02489-w
Xutong Zheng, Yuhong Zhang, Liuxuan Xie, Yingshuo Liu, Qiuying Yu, Han Zhang, Yao Li, Aiping Wang

Objectives: This systematic review investigates the barriers, enablers and mechanisms affecting ePROMs implementation in CKD (chronic kidney disease) management, with a focus on the perspectives of patients and healthcare providers.

Methods: A qualitative systematic review was conducted using the UK Medical Research Council's Process Evaluation Framework to analyze studies on ePROM implementation in CKD care. We systematically searched databases for peer-reviewed qualitative studies published from inception to October 2025. Thematic analysis, guided by the Process Evaluation Framework, was used to synthesize the findings. Studies from PubMed, Embase, Scopus, CINAHL, and APA PsycINFO were included.

Results: Results Eleven studies met the inclusion criteria. The synthesis identified distinct barriers and mechanisms of impact. Key barriers included structural and technical obstacles: digital literacy gaps, cognitive overload in vulnerable populations, misalignment with clinical IT systems, interface usability issues, and inconsistent implementation protocols. Regarding Enablers and Mechanisms, the review revealed a paradox. While ePROMs acted as enablers for personalized treatment and improved symptom awareness, their effectiveness was mediated by complex relational mechanisms. Both patients and clinicians expressed skepticism regarding utility in routine care. Furthermore, relational tensions arose when patient input was perceived as overlooked, highlighting that patient empowerment is conditional on the quality of the therapeutic alliance.

Conclusion: ePROMs have the potential to enhance CKD care by providing valuable insights into patient experiences. However, their adoption is hindered by digital literacy, technological issues, and inconsistent protocols. To optimize adoption, policymakers must prioritize IT integration and standardized protocols, while clinicians should actively incorporate results into consultations to validate patient input. Future research should focus on mixed-methods studies in diverse populations to ensure equitable and effective implementation.

目的:本系统综述调查了慢性肾脏疾病管理中影响eprom实施的障碍、促成因素和机制,重点关注患者和医疗保健提供者的观点。方法:采用英国医学研究委员会的过程评估框架进行定性系统评价,分析慢性肾病护理中ePROM实施的研究。我们系统地检索了数据库中从成立到2025年10月发表的同行评议的定性研究。在进程评价框架的指导下,采用专题分析来综合调查结果。包括PubMed、Embase、Scopus、CINAHL和APA PsycINFO的研究。结果:11项研究符合纳入标准。综合报告确定了明显的影响障碍和机制。主要障碍包括结构和技术障碍:数字素养差距、弱势群体的认知超载、与临床IT系统的不一致、界面可用性问题以及不一致的实施协议。关于促成因素和机制,审查揭示了一个悖论。虽然eprom作为个性化治疗和改善症状意识的推动者,但其有效性是由复杂的关系机制介导的。患者和临床医生都对常规护理的效用表示怀疑。此外,当患者的投入被认为被忽视时,关系紧张就会出现,强调患者的授权取决于治疗联盟的质量。结论:eprom通过对患者体验提供有价值的见解,有可能提高CKD的护理水平。然而,它们的采用受到数字素养、技术问题和不一致的协议的阻碍。为了优化采用率,政策制定者必须优先考虑IT集成和标准化协议,而临床医生应积极将结果纳入咨询,以验证患者的输入。今后的研究应侧重于在不同人群中进行混合方法研究,以确保公平和有效地实施。
{"title":"Implementing electronic Patient-Reported Outcome Measures in Chronic Kidney Disease: a qualitative systematic review of barriers, enablers, and mechanisms.","authors":"Xutong Zheng, Yuhong Zhang, Liuxuan Xie, Yingshuo Liu, Qiuying Yu, Han Zhang, Yao Li, Aiping Wang","doi":"10.1186/s12955-026-02489-w","DOIUrl":"https://doi.org/10.1186/s12955-026-02489-w","url":null,"abstract":"<p><strong>Objectives: </strong>This systematic review investigates the barriers, enablers and mechanisms affecting ePROMs implementation in CKD (chronic kidney disease) management, with a focus on the perspectives of patients and healthcare providers.</p><p><strong>Methods: </strong>A qualitative systematic review was conducted using the UK Medical Research Council's Process Evaluation Framework to analyze studies on ePROM implementation in CKD care. We systematically searched databases for peer-reviewed qualitative studies published from inception to October 2025. Thematic analysis, guided by the Process Evaluation Framework, was used to synthesize the findings. Studies from PubMed, Embase, Scopus, CINAHL, and APA PsycINFO were included.</p><p><strong>Results: </strong>Results Eleven studies met the inclusion criteria. The synthesis identified distinct barriers and mechanisms of impact. Key barriers included structural and technical obstacles: digital literacy gaps, cognitive overload in vulnerable populations, misalignment with clinical IT systems, interface usability issues, and inconsistent implementation protocols. Regarding Enablers and Mechanisms, the review revealed a paradox. While ePROMs acted as enablers for personalized treatment and improved symptom awareness, their effectiveness was mediated by complex relational mechanisms. Both patients and clinicians expressed skepticism regarding utility in routine care. Furthermore, relational tensions arose when patient input was perceived as overlooked, highlighting that patient empowerment is conditional on the quality of the therapeutic alliance.</p><p><strong>Conclusion: </strong>ePROMs have the potential to enhance CKD care by providing valuable insights into patient experiences. However, their adoption is hindered by digital literacy, technological issues, and inconsistent protocols. To optimize adoption, policymakers must prioritize IT integration and standardized protocols, while clinicians should actively incorporate results into consultations to validate patient input. Future research should focus on mixed-methods studies in diverse populations to ensure equitable and effective implementation.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the Japanese version of boredom proneness scale and derivation of its short version among older adults: a cross-sectional study. 日本版无聊倾向量表的验证及其在老年人中的推导:一项横断面研究。
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-04 DOI: 10.1186/s12955-026-02490-3
Atsushi Takayama, Izumi Uehara, Takashi Yoshioka, Taro Takeshima, Kenji Omae, Sayaka Shimizu, Hiroaki Nakagawa, Akihiro Ozaka, Sugihiro Hamaguchi, Shunichi Fukuhara
{"title":"Validation of the Japanese version of boredom proneness scale and derivation of its short version among older adults: a cross-sectional study.","authors":"Atsushi Takayama, Izumi Uehara, Takashi Yoshioka, Taro Takeshima, Kenji Omae, Sayaka Shimizu, Hiroaki Nakagawa, Akihiro Ozaka, Sugihiro Hamaguchi, Shunichi Fukuhara","doi":"10.1186/s12955-026-02490-3","DOIUrl":"https://doi.org/10.1186/s12955-026-02490-3","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A synthesis of dimensions of wellbeing among adolescents and young people living with HIV from Sub-Saharan Africa for measurement in economic evaluation: a qualitative overview of reviews. 撒哈拉以南非洲青少年和年轻艾滋病毒感染者福祉维度的综合,用于经济评估的测量:审查的定性概述。
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-04 DOI: 10.1186/s12955-026-02487-y
Stanley Carries, Juliet Nyasulu, Audrey Moyo, Eugene Lee Davids, Willem Odendaal, Darshini Govindasamy
{"title":"A synthesis of dimensions of wellbeing among adolescents and young people living with HIV from Sub-Saharan Africa for measurement in economic evaluation: a qualitative overview of reviews.","authors":"Stanley Carries, Juliet Nyasulu, Audrey Moyo, Eugene Lee Davids, Willem Odendaal, Darshini Govindasamy","doi":"10.1186/s12955-026-02487-y","DOIUrl":"https://doi.org/10.1186/s12955-026-02487-y","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health-related quality of life and associated factors among patients living with epilepsy of Mekelle City Hospitals, Northern Ethiopia: a multicenter observational study. 埃塞俄比亚北部Mekelle市医院癫痫患者的健康相关生活质量及相关因素:一项多中心观察性研究
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-03 DOI: 10.1186/s12955-026-02480-5
Gebremicheal Gebreyohanns Kahsay, Kidu Gidey, Alemseged Beyene Berha
{"title":"Health-related quality of life and associated factors among patients living with epilepsy of Mekelle City Hospitals, Northern Ethiopia: a multicenter observational study.","authors":"Gebremicheal Gebreyohanns Kahsay, Kidu Gidey, Alemseged Beyene Berha","doi":"10.1186/s12955-026-02480-5","DOIUrl":"https://doi.org/10.1186/s12955-026-02480-5","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146111956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health utility values associated with pharmaceutical treatment process attributes: a systematic review and meta-analysis. 与药物治疗过程属性相关的健康效用价值:一项系统回顾和荟萃分析。
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-02-02 DOI: 10.1186/s12955-026-02485-0
Yun Liu, Xinyu Du, Zheng Rong, Zhen Guo, Feng Chang, Yun Lu, Zhanjing Dai, Yuqiong Lu
<p><strong>Background: </strong>In cases where clinical efficacy and safety profiles are similar, patient preferences for the treatment process become a critical determinant of therapeutic adherence and health-related quality of life (HRQoL). However, current research on the utility of treatment process attributes (such as administration route, frequency, and time) show significant heterogeneity. Moreover, the results are often influenced by confounding factors, making it difficult to quantify their independent utility impact.</p><p><strong>Objectives: </strong>This study aims to deconstruct prevalent confounding biases through a systematic review and multivariable meta-regression. The goal is to isolate the independent effects of various treatment process attributes on health utility values, thereby providing more precise evidence for pharmacoeconomic evaluations.</p><p><strong>Methods: </strong>Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this study systematically searched PubMed, Cochrane Library, Web of Science, and EBSCO databases for relevant English-language literature published up to December 2024. Original research reporting health utility values (on a 0-1 scale) associated with pharmaceutical treatment process attributes was included. Extracted disutility values, defined as Disutility=Utility - 1, were analyzed using random-effects models. Univariate, bivariate, and multivariable meta-regression models were constructed to control for key confounders, such as disease type and respondent population (patients vs. general public), and to investigate the independent effects of administration route, frequency, and duration on utility values.</p><p><strong>Results: </strong>Nineteen studies (providing 81 utility values) met inclusion criteria. In fully adjusted models, administration route emerged as a primary determinant of utility. Injection (versus oral) conferred a significant disutility (β = - 0.092; 95% CI - 0.127 to - 0.056; p < 0.001). Administration durations > 1 h also imposed significant disutility (β = - 0.172; 95% CI - 0.289 to - 0.055; p < 0.005). Disease severity was the strongest predictor overall: utilities for neoplasms were over 0.4 lower than for metabolic conditions (p < 0.001). Patients consistently reported higher utilities than the general public. An apparent "frequency paradox" (greater disutility for lower dosing frequency) emerged in unadjusted analysis, but this effect disappeared after adjusting for route, indicating it was a statistical artifact of confounding by route. No independent effect of dosing frequency remained in multivariable analysis.</p><p><strong>Conclusion: </strong>Injectable route and prolonged administration duration are significant, independent drivers of health disutility. The apparent negative effect of dosing frequency is a statistical artifact of confounding by the administration route, which carries the actual disutility. These findin
背景:在临床疗效和安全性相似的情况下,患者对治疗过程的偏好成为治疗依从性和健康相关生活质量(HRQoL)的关键决定因素。然而,目前对治疗过程属性(如给药途径、频率和时间)效用的研究显示出显著的异质性。此外,结果往往受到混杂因素的影响,使其难以量化其独立的效用影响。目的:本研究旨在通过系统回顾和多变量元回归分析来解构普遍存在的混淆偏差。目的是分离各种治疗过程属性对健康效用值的独立影响,从而为药物经济学评估提供更精确的证据。方法:本研究遵循PRISMA (Preferred Reporting Items for Systematic Reviews and meta - analysis)指南,系统检索PubMed、Cochrane Library、Web of Science和EBSCO数据库,检索截止2024年12月发表的相关英文文献。纳入了报告与药物处理过程属性相关的健康效用值(0-1分)的原始研究。提取的负效用值定义为负效用=效用- 1,使用随机效应模型进行分析。建立了单变量、双变量和多变量元回归模型来控制关键混杂因素,如疾病类型和应答人群(患者与公众),并调查给药途径、频率和持续时间对效用值的独立影响。结果:19项研究(提供81个实用价值)符合纳入标准。在完全调整后的模型中,给药途径成为效用的主要决定因素。注射(与口服相比)具有显著的负效用(β = - 0.092; 95% CI - 0.127至- 0.056;p 1 h也具有显著的负效用(β = - 0.172; 95% CI - 0.289至- 0.055);p结论:注射途径和延长给药时间是显著的、独立的健康负效用驱动因素。给药频率的明显负面影响是由给药途径混淆的统计伪影,它带来了实际的负效用。这些发现强调了治疗属性的相互联系,并强调了一种整体的、多变量的测量方法是必要的,以避免药物经济学评估中混淆偏倚的错误结论。
{"title":"Health utility values associated with pharmaceutical treatment process attributes: a systematic review and meta-analysis.","authors":"Yun Liu, Xinyu Du, Zheng Rong, Zhen Guo, Feng Chang, Yun Lu, Zhanjing Dai, Yuqiong Lu","doi":"10.1186/s12955-026-02485-0","DOIUrl":"https://doi.org/10.1186/s12955-026-02485-0","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;In cases where clinical efficacy and safety profiles are similar, patient preferences for the treatment process become a critical determinant of therapeutic adherence and health-related quality of life (HRQoL). However, current research on the utility of treatment process attributes (such as administration route, frequency, and time) show significant heterogeneity. Moreover, the results are often influenced by confounding factors, making it difficult to quantify their independent utility impact.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;This study aims to deconstruct prevalent confounding biases through a systematic review and multivariable meta-regression. The goal is to isolate the independent effects of various treatment process attributes on health utility values, thereby providing more precise evidence for pharmacoeconomic evaluations.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this study systematically searched PubMed, Cochrane Library, Web of Science, and EBSCO databases for relevant English-language literature published up to December 2024. Original research reporting health utility values (on a 0-1 scale) associated with pharmaceutical treatment process attributes was included. Extracted disutility values, defined as Disutility=Utility - 1, were analyzed using random-effects models. Univariate, bivariate, and multivariable meta-regression models were constructed to control for key confounders, such as disease type and respondent population (patients vs. general public), and to investigate the independent effects of administration route, frequency, and duration on utility values.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Nineteen studies (providing 81 utility values) met inclusion criteria. In fully adjusted models, administration route emerged as a primary determinant of utility. Injection (versus oral) conferred a significant disutility (β = - 0.092; 95% CI - 0.127 to - 0.056; p &lt; 0.001). Administration durations &gt; 1 h also imposed significant disutility (β = - 0.172; 95% CI - 0.289 to - 0.055; p &lt; 0.005). Disease severity was the strongest predictor overall: utilities for neoplasms were over 0.4 lower than for metabolic conditions (p &lt; 0.001). Patients consistently reported higher utilities than the general public. An apparent \"frequency paradox\" (greater disutility for lower dosing frequency) emerged in unadjusted analysis, but this effect disappeared after adjusting for route, indicating it was a statistical artifact of confounding by route. No independent effect of dosing frequency remained in multivariable analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Injectable route and prolonged administration duration are significant, independent drivers of health disutility. The apparent negative effect of dosing frequency is a statistical artifact of confounding by the administration route, which carries the actual disutility. These findin","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between disease status and health-related quality of life: evidence from a cross-sectional survey across mainland China. 疾病状况与健康相关生活质量的关系:来自中国大陆横断面调查的证据
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-31 DOI: 10.1186/s12955-026-02481-4
Xinyi Li, Xuedi Ma, Changcheng Shi, Wangjun Qin, Yibo Wu, Lihong Liu
{"title":"The association between disease status and health-related quality of life: evidence from a cross-sectional survey across mainland China.","authors":"Xinyi Li, Xuedi Ma, Changcheng Shi, Wangjun Qin, Yibo Wu, Lihong Liu","doi":"10.1186/s12955-026-02481-4","DOIUrl":"https://doi.org/10.1186/s12955-026-02481-4","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring relative health spillover effects within the context of dementia using the EQ-HWB-9. 利用EQ-HWB-9探索痴呆背景下的相对健康溢出效应。
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-31 DOI: 10.1186/s12955-026-02486-z
Valeriia Sokolova, Jan Faller, Thao Thai, Lidia Engel

Background: Dementia does not only impact the quality of life of the affected individual but also their family and informal caregivers, often referred to as health spillover effects. Increasing attention is being given to the inclusion of informal caregiver spillover effects in economic evaluations, given their potential to directly influence funding recommendations.

Objective: The objective of this study was to estimate the relative health spillover effects of dementia caregiving on informal caregivers using the EQ Health and Wellbeing 9-items (EQ-HWB-9) questionnaire.

Methods: A cross-sectional survey was conducted involving informal caregivers of people with dementia residing in Australia. Informal caregivers completed the experimental version of EQ-HWB to rate their own health and wellbeing and proxy reported for the person with dementia using the EQ-HWB-9. To estimate the relative spillover, univariate and multiple linear regressions modeled caregiver's EQ-HWB-9 scores (derived from the EQ-HWB) as a function of the person with dementia health and wellbeing (based on the EQ-HWB-9), adjusting for demographic and caregiving characteristics.

Results: In total, 202 informal caregivers completed the survey. The average age of caregivers was 60.4 (SD = 13.7), with 63.2% being female. The univariate analysis revealed a positive relative spillover effect coefficient of 0.23 (p < 0.001, R-squared = 0.10), demonstrating a significant positive association between caregiver's and person's with dementia health and wellbeing using the EQ-HWB-9. This relationship remained significant (p < 0.001, adj R-squared = 0.26) when adjusting for caregiver's chronic conditions in the multiple linear regression model yielding a spillover coefficient of 0.22. Most impacted domains of caregiving included exhaustion, loneliness and lack of control over day-to-day life.

Conclusions: There is evidence of associative relative health spillovers associated with providing informal care for a person with dementia. It is essential to include health effects on informal caregivers into economic evaluations to account for the burden of dementia posed beyond the affected individual.

背景:痴呆症不仅影响患者的生活质量,还影响其家庭和非正式照顾者,这通常被称为健康溢出效应。鉴于非正式照顾者的溢出效应有可能直接影响到供资建议,因此越来越注意将其纳入经济评价。目的:本研究的目的是利用情商健康与幸福9项(EQ- hwb -9)问卷评估痴呆症护理对非正式照顾者的相对健康溢出效应。方法:对居住在澳大利亚的痴呆症患者的非正式照顾者进行横断面调查。非正式护理人员完成了EQ-HWB的实验版本,以评估他们自己的健康和福祉,并使用EQ-HWB-9为痴呆症患者报告代理。为了估计相对溢出,单变量和多元线性回归将护理人员的EQ-HWB-9分数(来自EQ-HWB)建模为痴呆症患者健康和福祉的函数(基于EQ-HWB-9),并根据人口统计学和护理特征进行调整。结果:共有202名非正式护理人员完成了调查。护理人员的平均年龄为60.4岁(SD = 13.7),女性占63.2%。单变量分析显示,正的相对溢出效应系数为0.23 (p)。结论:有证据表明,为痴呆症患者提供非正式护理存在相关的相对健康溢出效应。必须将对非正式照护者的健康影响纳入经济评估,以考虑痴呆症对受影响个人以外的人造成的负担。
{"title":"Exploring relative health spillover effects within the context of dementia using the EQ-HWB-9.","authors":"Valeriia Sokolova, Jan Faller, Thao Thai, Lidia Engel","doi":"10.1186/s12955-026-02486-z","DOIUrl":"https://doi.org/10.1186/s12955-026-02486-z","url":null,"abstract":"<p><strong>Background: </strong>Dementia does not only impact the quality of life of the affected individual but also their family and informal caregivers, often referred to as health spillover effects. Increasing attention is being given to the inclusion of informal caregiver spillover effects in economic evaluations, given their potential to directly influence funding recommendations.</p><p><strong>Objective: </strong>The objective of this study was to estimate the relative health spillover effects of dementia caregiving on informal caregivers using the EQ Health and Wellbeing 9-items (EQ-HWB-9) questionnaire.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted involving informal caregivers of people with dementia residing in Australia. Informal caregivers completed the experimental version of EQ-HWB to rate their own health and wellbeing and proxy reported for the person with dementia using the EQ-HWB-9. To estimate the relative spillover, univariate and multiple linear regressions modeled caregiver's EQ-HWB-9 scores (derived from the EQ-HWB) as a function of the person with dementia health and wellbeing (based on the EQ-HWB-9), adjusting for demographic and caregiving characteristics.</p><p><strong>Results: </strong>In total, 202 informal caregivers completed the survey. The average age of caregivers was 60.4 (SD = 13.7), with 63.2% being female. The univariate analysis revealed a positive relative spillover effect coefficient of 0.23 (p < 0.001, R-squared = 0.10), demonstrating a significant positive association between caregiver's and person's with dementia health and wellbeing using the EQ-HWB-9. This relationship remained significant (p < 0.001, adj R-squared = 0.26) when adjusting for caregiver's chronic conditions in the multiple linear regression model yielding a spillover coefficient of 0.22. Most impacted domains of caregiving included exhaustion, loneliness and lack of control over day-to-day life.</p><p><strong>Conclusions: </strong>There is evidence of associative relative health spillovers associated with providing informal care for a person with dementia. It is essential to include health effects on informal caregivers into economic evaluations to account for the burden of dementia posed beyond the affected individual.</p>","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146097000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy. 口服抗凝治疗患者EQ-5D-5L与SF-6D量表的比较研究
IF 3.4 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2026-01-30 DOI: 10.1186/s12955-026-02483-2
Shujie Dong, Yajing Li, Ziqiong Liao, Qi Lin, Hei Hang Edmund Yiu, Wai-Kit Ming, Lei Li, Rongsheng Zhao
{"title":"A comparative study of EQ-5D-5L and SF-6D scales based on patients receiving oral anticoagulant therapy.","authors":"Shujie Dong, Yajing Li, Ziqiong Liao, Qi Lin, Hei Hang Edmund Yiu, Wai-Kit Ming, Lei Li, Rongsheng Zhao","doi":"10.1186/s12955-026-02483-2","DOIUrl":"https://doi.org/10.1186/s12955-026-02483-2","url":null,"abstract":"","PeriodicalId":12980,"journal":{"name":"Health and Quality of Life Outcomes","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146092978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health and Quality of Life Outcomes
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1